NCT03896737 2025-08-11Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-DaraEuropean Myeloma Network B.V.Phase 2 Active not recruiting401 enrolled